MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2021.728319

Медицинская библиотека · Frontiers in oncology · 2021

RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study.

Nicolè Lorenzo, Cappello Filippo, Cappellesso Rocco, Piccin Luisa, Ventura Laura, Guzzardo Vincenza, Del Fiore Paolo, Chiarion-Sileni Vanna, Dei Tos Angelo Paolo, Mocellin Simone, Fassina Ambrogio

СтатьяПеревод пока не подготовлен

Аннотация

Malignant melanoma (MM) is the most lethal skin cancer. AXL is a tyrosine kinase receptor involved in several oncogenic processes and might play a role in blocking necroptosis (a regulated cell death mechanism) in MM through the downregulation of the necroptotic-related driver RIPK3. The aim of this study was to evaluate the clinical impact of the expression of AXL and RIPK3 in 108 primary cutaneous MMs. Association between AXL and RIPK3 immunoreactivity and clinical-pathological variables, sentinel lymph node status, and tumor-infiltrating lymphocytes (TILs) was assessed. Immunoreaction in tumor cells was detected in 30 cases (28%; range, 5%-80%) and in 17 cases (16%; range, 5%-50%) for AXL and RIPK3, respectively. Metastases in the sentinel lymph nodes were detected in 14 out of 61 patients, and these were associated with AXL-positive immunoreactivity in the primary tumor (p < 0.0001). No association between AXL and TILs was found. RIPK3 immunoreactivity was not associated with any variables. A final logistic regression analysis showed Breslow and AXL-positive immunoreactivity as the stronger predictor for positive sentinel node status [area under the receiver operating characteristic curve (AUC) of 0.96]. AXL could be a potential new biomarker for MM risk assessment, and it deserves to be further investigated in larger studies.

Для цитирования: Nicolè Lorenzo, Cappello Filippo, Cappellesso Rocco, Piccin Luisa, Ventura Laura, Guzzardo Vincenza, Del Fiore Paolo, Chiarion-Sileni Vanna, Dei Tos Angelo Paolo, Mocellin Simone, Fassina Ambrogio. RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study.. Frontiers in oncology. 2021. DOI: 10.3389/fonc.2021.728319.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.